908 Devices (NASDAQ:MASS – Get Free Report) issued its quarterly earnings data on Tuesday. The company reported ($0.32) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.14) by ($0.18), FiscalAI reports. 908 Devices had a negative net margin of 62.40% and a negative return on equity of 14.03%. The company had revenue of $16.07 million for the quarter, compared to the consensus estimate of $15.37 million.
Here are the key takeaways from 908 Devices’ conference call:
- Second-quarter revenue rose 23% year over year to $16.1 million, while 198 devices were shipped and the installed base reached 4,101. U.S. state and local customers contributed more than half of quarterly revenue, supported by demand for modernized detection equipment.
- Profitability improved meaningfully, with adjusted EBITDA loss narrowing to $1.9 million from $3.9 million a year earlier and adjusted gross margin expanding to 57%. Management raised the low end of full-year 2026 revenue guidance to $68 million-$70 million, or 21%-25% growth.
- The NIRLab acquisition is gaining early traction, with more than 35 devices sold in roughly two months, each including a multiyear software subscription. Management sees cross-selling potential with MX908 and other products and aspires to increase recurring revenue from its current 31% of total revenue toward 40% over time.
- The AVCAD military program remains unresolved after its current contract ended, with the government evaluating both a continued development path and commercially available products. The company excluded AVCAD from 2026 guidance, although any contribution would be upside and management continues to view it as a potential $10 million-plus long-term opportunity.
- The company ended the quarter with $101.5 million in cash and no debt, but consumed $10.2 million during the quarter, including $13.5 million for the NIRLab acquisition. Management continues to target a mid-single-digit-million adjusted EBITDA loss for 2026 rather than breakeven.
908 Devices Stock Performance
Shares of NASDAQ:MASS opened at $9.10 on Tuesday. The company has a 50 day moving average price of $8.21 and a two-hundred day moving average price of $7.31. The company has a market capitalization of $343.96 million, a PE ratio of -8.99 and a beta of 0.66. 908 Devices has a 52 week low of $5.03 and a 52 week high of $9.34.
Insider Activity at 908 Devices
Institutional Inflows and Outflows
Hedge funds have recently added to or reduced their stakes in the company. AQR Capital Management LLC acquired a new stake in shares of 908 Devices during the first quarter valued at about $365,000. Geode Capital Management LLC increased its stake in 908 Devices by 11.7% during the 2nd quarter. Geode Capital Management LLC now owns 658,603 shares of the company’s stock valued at $4,697,000 after purchasing an additional 68,764 shares in the last quarter. Rhumbline Advisers boosted its position in shares of 908 Devices by 5.5% during the second quarter. Rhumbline Advisers now owns 36,416 shares of the company’s stock valued at $260,000 after buying an additional 1,894 shares during the last quarter. American Century Companies Inc. boosted its holdings in 908 Devices by 22.9% during the second quarter. American Century Companies Inc. now owns 56,296 shares of the company’s stock worth $401,000 after purchasing an additional 10,482 shares during the last quarter. Finally, Walleye Capital LLC purchased a new position in 908 Devices in the second quarter worth $82,000. 88.06% of the stock is owned by institutional investors.
Wall Street Analysts Forecast Growth
Several brokerages have weighed in on MASS. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of 908 Devices in a research report on Friday. Roth Capital started coverage on 908 Devices in a research report on Wednesday, July 29th. They issued a “buy” rating and a $11.00 price target for the company. Finally, Wall Street Zen lowered 908 Devices from a “buy” rating to a “hold” rating in a report on Saturday, July 18th. One investment analyst has rated the stock with a Buy rating and one has issued a Sell rating to the company. According to MarketBeat, the stock presently has an average rating of “Hold” and an average price target of $11.00.
View Our Latest Stock Report on MASS
908 Devices Company Profile
908 Devices Inc (NASDAQ: MASS) is a developer and manufacturer of portable analytical instruments designed to deliver rapid chemical detection in field and laboratory environments. The company’s core focus lies in miniaturizing high-performance mass spectrometry and ion mobility spectrometry technologies, enabling users to perform on-site analysis that traditionally required benchtop equipment.
Key products in 908 Devices’ portfolio include the MX908, a handheld high-resolution mass spectrometer capable of detecting and identifying a broad range of chemicals and explosives; the M908 portable mass spectrometer for laboratory or mobile units; and the ZipChip capillary electrophoresis system for high-throughput, microfluidic separations.
Read More
- Five stocks we like better than 908 Devices
- 3 Companies That Could Thrive While the Fed Holds Rates Steady
- Caterpillar’s Blowout Quarter May Point to More Industrial Winners
- Jeff Bezos’ Amazon Sale Looks Less Alarming Than the Headline Suggests
- 3 Overlooked Stocks Analysts Still Like as AI Trades Get Crowded
Receive News & Ratings for 908 Devices Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 908 Devices and related companies with MarketBeat.com's FREE daily email newsletter.
